Clinical Trials on Advanced Nonhematological Neoplasms in United Kingdom
Total 49890 results
-
Eli Lilly and CompanyCompletedAdvanced CancerBelgium, United States, Korea, Republic of, Australia, France
-
Mayo ClinicCompletedAdvanced Cancer | Family CaregiversUnited States
-
Leonard ApplemanAstraZenecaCompletedAdvanced Incurable Solid MalignancyUnited States
-
SCRI Development Innovations, LLCNovartisCompletedAdvanced Malignancies | Refractory MalignancyUnited States
-
Imperial College LondonRecruiting
-
Gannex Pharma Co., Ltd.Ascletis Pharmaceuticals Co., Ltd.RecruitingAdvanced Solid TumorsUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedAdvanced Solid TumorsCanada, United States
-
Onconova Therapeutics, Inc.TerminatedNeoplasms | Advanced Solid TumorUnited States
-
PfizerCompletedAdvanced Solid TumorsUnited States
-
Arog Pharmaceuticals, Inc.CompletedAdvanced Solid TumorsUnited States, Australia
-
M.D. Anderson Cancer CenterOtsuka Pharmaceutical Development & Commercialization, Inc.Completed
-
Sunesis PharmaceuticalsCompletedAdvanced Solid TumorsUnited States
-
Bristol-Myers SquibbTerminatedAdvanced Solid MalignanciesUnited States, Canada
-
CDR-Life AGRecruitingSelect Advanced Solid TumorsUnited States, Denmark
-
Lantern Pharma Inc.Recruiting
-
Innate PharmaAstraZenecaTerminatedAdvanced Solid TumorsUnited States, France
-
CelgeneCompleted
-
M.D. Anderson Cancer CenterActive, not recruitingAdvanced Malignant Solid NeoplasmUnited States
-
Tianhong LiNational Cancer Institute (NCI); OncoImmune, Inc.TerminatedAdvanced Malignant Solid NeoplasmUnited States
-
Janssen Research & Development, LLCActive, not recruitingAdvanced Solid TumorFrance, United States, Japan, Belgium, United Kingdom, Germany, Korea, Republic of, Taiwan, China, Poland, Italy, Spain, Australia, Brazil, Argentina
-
Regeneron PharmaceuticalsWithdrawnAdvanced MalignanciesUnited States
-
Shanghai YingLi Pharmaceutical Co. Ltd.Not yet recruitingAdvanced Solid TumorsUnited States
-
Georgiamune IncRecruitingAdvanced Solid MalignanciesUnited States
-
Mirati Therapeutics Inc.Active, not recruitingAdvanced Solid TumorUnited States
-
AmgenCompletedCancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States
-
LaNova Medicines LimitedTerminatedAdvanced Solid TumorUnited States
-
Hoffmann-La RocheCompletedAdvanced Solid TumorsUnited States, France
-
Eli Lilly and CompanyCompleted
-
BayerCompleted
-
ImmunoGen, Inc.MacroGenicsCompletedAdvanced Solid TumorUnited States, Italy, Spain
-
Novartis PharmaceuticalsCompletedSolid Tumors | Advanced MalignanciesUnited States
-
DynamiCure BiotechnologyTerminatedAdvanced or Metastatic Solid TumorsUnited States
-
Reata, a wholly owned subsidiary of BiogenCompletedAdvanced Solid Tumors | Lymphoid MalignanciesUnited States
-
TaiRx, Inc.CompletedCarcinoma | Advanced CancerUnited States
-
Eli Lilly and CompanyCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingAdvanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Metastatic Malignant Neoplasm in the Liver | Metastatic Malignant Neoplasm in the LungUnited States
-
Massachusetts General HospitalCompletedAdvanced Cancer | Home Care, Hospital-BasedUnited States
-
Royal Marsden NHS Foundation TrustPfizer; Hoffmann-La RocheRecruitingAdvanced Breast Cancer | Metastatic Breast Cancer | ER+ Breast CancerUnited Kingdom
-
AstraZenecaCompletedAdvanced Ovarian Cancer | Paclitaxel | Carboplatin | Triple Negative Metastatic Breast CancerBelgium, Netherlands, United Kingdom
-
Gilead SciencesRecruitingAdvanced Solid TumorsUnited States, Israel
-
Novartis PharmaceuticalsCompletedA Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic FunctionAdvanced Malignancies | TumorsUnited States
-
CelgeneCompletedAdvanced Solid TumorsUnited States
-
Taiho Oncology, Inc.TerminatedAdvanced Solid TumorsUnited States
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedAdvanced Solid TumorsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMethylphenidate and Physical Activity to Reduce Cancer Related Fatigue Due to Anti PD1 ImmunotherapyMetastatic Malignant Neoplasm | Advanced Malignant Neoplasm | Recurrent Malignant NeoplasmUnited States
-
Mast Therapeutics, Inc.CompletedAdvanced CancerUnited States, Argentina, Estonia
-
Eikon TherapeuticsImpact Therapeutics, Inc.RecruitingAdvanced Solid TumorAustralia, United States
-
Cullinan Therapeutics Inc.RecruitingAdvanced Solid TumorUnited States
-
Mural Oncology, IncRecruitingAdvanced Solid TumorUnited States, Spain
-
1200 Pharma, LLCTerminatedAdvanced Solid TumorUnited States